Pharming Group N.V. (PHAR)
NASDAQ: PHAR · Real-Time Price · USD
15.44
-0.39 (-2.46%)
At close: Mar 6, 2026, 4:00 PM EST
15.44
0.00 (0.00%)
After-hours: Mar 6, 2026, 4:10 PM EST
Pharming Group Employees
Pharming Group had 404 employees as of December 31, 2024. The number of employees increased by 22 or 5.76% compared to the previous year.
Employees
404
Change (1Y)
22
Growth (1Y)
5.76%
Revenue / Employee
$896,718
Profits / Employee
$946
Market Cap
1.06B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 404 | 22 | 5.76% |
| Dec 31, 2023 | 382 | 50 | 15.06% |
| Dec 31, 2022 | 332 | 55 | 19.86% |
| Dec 31, 2021 | 277 | 15 | 5.73% |
| Dec 31, 2020 | 262 | 50 | 23.58% |
| Jan 1, 2020 | 212 | 29 | 15.85% |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| AbCellera Biologics | 596 |
| Xeris Biopharma Holdings | 394 |
| UroGen Pharma | 287 |
| Geron | 229 |
| Inhibrx Biosciences | 161 |
| Precigen | 143 |
| DBV Technologies | 117 |
| Inventiva | 84 |
PHAR News
- 3 days ago - INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pharming Group N.V. - PHAR - GlobeNewsWire
- 8 days ago - INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pharming Group N.V. - PHAR - PRNewsWire
- 8 days ago - Pharming Group to report fourth quarter and full year 2025 financial results and provide business update on March 12 - GlobeNewsWire
- 14 days ago - INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pharming Group N.V. - PHAR - PRNewsWire
- 17 days ago - INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pharming Group N.V. - PHAR - GlobeNewsWire
- 17 days ago - Pharming Group to present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference - GlobeNewsWire
- 4 weeks ago - Pharming Group: Crossing From Speculation To Profitability - Seeking Alpha
- 4 weeks ago - Pharming Group N.V. (PHAR) Analyst/Investor Day Transcript - Seeking Alpha